Ranking mAb-excipient interactions in biologics formulations by NMR spectroscopy and computational approaches

Chunting Zhang1, Steven T Gossert1, Jonathan Williams1

  • 1Drug Product Development, Bristol Myers Squibb, New Brunswick, NJ, USA.

Mabs
|May 23, 2023
PubMed
Summary

Understanding how excipients stabilize monoclonal antibodies (mAbs) is crucial. This study used NMR and simulations to directly measure mAb-excipient binding, aiding biologic formulation development.

Related Concept Videos